KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT04601610 · TERMINATED
Trial details
- NCT number
- NCT04601610
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-07
- Primary completion
- 2022-05-30
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.